|Generate QR code
Open Access
Subscription Access
Diff erential diagnostics of lymphadenopathy: lymphoma in the clinical practice
https://doi.org/10.30629/0023-2149-2025-103-3-229-232
Abstract
A doctor of any specialty has to deal with lymphadenopathy (LAP), which is a symptom of various diseases. The diff erential diagnosis of LAP in lymphoproliferative diseases is important due to the high mortality rate in this pathology. The article presents a clinical case describing the diffi culties of diff erential diagnosis of LAP and verifi cation of T-cell lymphoma
About the Authors
M. A. Shalenkova
Clinical Hospital No. 38
Russian Federation
Russian Federation
Maria A. Shalenkova — Doctor of Medical Sciences, Professor, consultant
Nizhniy Novgorod
E. T. Manyukova
Clinical Hospital No. 38
Russian Federation
Russian Federation
Elvira T. Manyukova — Candidate of Medical Sciences, consultant
Nizhniy Novgorod
L. P. Muravyova
Clinical Hospital No. 12
Russian Federation
Russian Federation
Lyudmila P. Muravyova — Can didate of Medical Sciences, Associate Professor, Doctor of the Hematology Department
Nizhniy Novgorod
V. V. Muravyov
Clinical Hospital No. 12
Russian Federation
Russian Federation
Vladimir V. Muravyov — Candidate of Medical Sciences, Head of the Hematology Department
Nizhniy Novgorod
E. G. Tarasova
Clinical Hospital No. 12
Russian Federation
Russian Federation
Elena G. Tarasova — doctor at the Hematology Department
Nizhniy Novgorod
References
1. Maini R., Nagalli S. Lymphadenopathy. Updated 2022 Aug 8. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing. 2024 Jan. URL: https://www.ncbi.nlm.nih.gov/books/NBK558918/
2. Freeman A.M, Matto P. Adenopathy. 2023 Feb 20. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing. 2024 Jan. URL: https://pubmed.ncbi.nlm.nih.gov/30020622/
3. Gaddey H.L., Riegel A.M. Unexplained lymphadenopathy: Evaluation and diff erential diagnosis. American Family Physician. 2016;94 (11):896–903. URL: https://pubmed.ncbi.nlm.nih.gov/27929264/
4. National clinical guidelines for the diagnosis of lymphadenopathy. M. 2018:30. (Approved by the Ministry of Health of the Russian Federation)
5. Terret C., Albrand G., Rainfray M., Soubeyran P. Impact of comorbidities on the treatment of non-Hodgkin’s lymphoma: a systematic review. Expert review of hematology. 2015;8(3):329–41. DOI: 10.1586/17474086.2015.1024650
6. Kamolova F.Sh., Mudunov A.M., Zeynalova P.A., Grivtsova L.Yu., Allakhverdiyeva G.F., Azizyan R.I. et al. Epidemiological and clinical features of lymphoproliferative diseases in the head and neck region. Onkogematologiya = Oncohematology 2021;16(3):105–17. (In Russian). DOI: 10.17650/1818-8346-2021-16-3-105-117
7. Malignant tumors in Russia in 2021 (morbidity and mortality). Ed. by Kaprin A.D., Starinsky V.V., Shakhzadova A.O. Moscow, 2022:252. (In Russian).
8. Mirzaakhmedova I.Z. Frequency of chronic hemoblastosis and age features. Ekonomika i sotsium. 2022;3(94)– 2:695–698. (In Russia). URL: https://www.iupr.ru/_files/ugd/b06fdc_c698324717aa4f20addc539e81c5f310.pdf?index=true
9. Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases. Ed. by Poddubnoy I.V., Savchenko V.G. М. 2018:324. (In Russian).
10. Belov B.S, Ananyeva L.P. Lyme disease: мodern approaches to prevention, diagnosis and treatment. Nauchcno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(5):547–554 (In Russian). DOI: 10.47360/1995-4484-2021-547-554
11. Diagnostic algorithms and treatment protocols for diseases of the blood system: in two volumes. Ed. by Parovichnikovoj E.N. Volume 2. М. Practice. 2024:768. (In Russian).
Review
For citations:
Shalenkova M.A., Manyukova E.T., Muravyova L.P., Muravyov V.V., Tarasova E.G. Diff erential diagnostics of lymphadenopathy: lymphoma in the clinical practice. Clinical Medicine (Russian Journal). 2025;103(3):229-232. (In Russ.) https://doi.org/10.30629/0023-2149-2025-103-3-229-232
Views:
15
Email this article 